What are the Challenges in Anti-VEGF Therapy from an Epidemiological Perspective?
While Anti-VEGF therapies are effective, they come with challenges:
Accessibility: Not all patients have equal access to these treatments, particularly in low-resource settings. Cost: Anti-VEGF agents can be expensive, posing a financial burden on both patients and healthcare systems. Compliance: Regular intravitreal injections are required, which can be burdensome for patients. Resistance: Some patients may develop resistance to Anti-VEGF agents, necessitating alternative treatments.
